Literature DB >> 3105138

Orthoclone OKT3 treatment of acute renal allograft rejection in patients receiving maintenance cyclosporine therapy.

R L Hirsch, P C Layton, L A Barnes, A B Kremer, G Goldstein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3105138

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

Review 1.  The role of OKT3 in clinical transplantation.

Authors:  D J Norman; M R Leone
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

Review 2.  Muromonab CD3. A review of its pharmacology and therapeutic potential.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

3.  Treatment of acute kidney allograft rejection with a non-mitogenic CD3 antibody.

Authors:  R T Meijer; S Surachno; S L Yong; F J Bemelman; S Florquin; I J M Ten Berge; P T A Schellekens
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.